ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Genesis Molecular AI
Genesis Molecular AI is building a team of top-tier computational chemists to advance drug discovery through machine learning and biophysical simulations. The role involves collaborating with both wet lab and computational teams to develop AI-powered tools for small molecule drug design.
Genesis Molecular AI is a biotechnology company delivering the industry’s most advanced molecular AI platform to unlock tough protein targets and accelerate drug discovery at scale. Its platform combines AI-driven analytics with molecular understanding to identify viable targets and design candidate medicines more efficiently. The solution is tailored for biotech and pharmaceutical teams seeking scalable, data-driven discovery workflows that shorten preclinical timelines. Genesis positions itself as a leader in AI-enabled drug discovery, helping researchers move faster from target to medicine.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genesis Molecular AI.
31% below the average for this role